These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 2961786

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF, Crawford JD, Crowley WF.
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [Abstract] [Full Text] [Related]

  • 4. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA, Rothenberg S, Blumberg D, Oberfield SE, Levine LS, David R.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [Abstract] [Full Text] [Related]

  • 5. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [Abstract] [Full Text] [Related]

  • 6. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
    Rappaport R, Prevot C, Brauner R.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
    [Abstract] [Full Text] [Related]

  • 7. The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty.
    DiMartino-Nardi J, Wu R, Fishman K, Saenger P.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):902-6. PubMed ID: 1909708
    [Abstract] [Full Text] [Related]

  • 8. Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche.
    Wierman ME, Beardsworth DE, Crawford JD, Crigler JF, Mansfield MJ, Bode HH, Boepple PA, Kushner DC, Crowley WF.
    J Clin Invest; 1986 Jan; 77(1):121-6. PubMed ID: 2935557
    [Abstract] [Full Text] [Related]

  • 9. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
    Manasco PK, Pescovitz OH, Feuillan PP, Hench KD, Barnes KM, Jones J, Hill SC, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
    [Abstract] [Full Text] [Related]

  • 10. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

  • 11. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.
    Attie KM, Ramirez NR, Conte FA, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1990 Oct; 71(4):975-83. PubMed ID: 2401720
    [Abstract] [Full Text] [Related]

  • 12. Impact of sex steroids and their suppression on skeletal growth and maturation.
    Boepple PA, Mansfield MJ, Link K, Crawford JD, Crigler JF, Kushner DC, Blizzard RM, Crowley WF.
    Am J Physiol; 1988 Oct; 255(4 Pt 1):E559-66. PubMed ID: 3052107
    [Abstract] [Full Text] [Related]

  • 13. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
    Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC, Cutler GB.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
    [Abstract] [Full Text] [Related]

  • 14. The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein.
    DiMartino-Nardi J, Wu R, Varner R, Wong WL, Saenger P.
    J Clin Endocrinol Metab; 1994 Mar; 78(3):664-8. PubMed ID: 8126139
    [Abstract] [Full Text] [Related]

  • 15. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M, Francois R, Garandeau P, Lahlou N, Morel Y.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [Abstract] [Full Text] [Related]

  • 16. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [Abstract] [Full Text] [Related]

  • 17. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
    Hertel NT, Stoltenberg M, Juul A, Main KM, Müller J, Nielsen CT, Lorenzen I, Skakkebaek NE.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
    [Abstract] [Full Text] [Related]

  • 18. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ, Hümmelink R, Peter M, Sippell WG, Oostdijk W, Odink RJ, Drop SL.
    Horm Res; 1993 Apr; 39(3-4):111-7. PubMed ID: 8262471
    [Abstract] [Full Text] [Related]

  • 19. Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment.
    Sørensen K, Andersson AM, Skakkebaek NE, Juul A.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3189-96. PubMed ID: 17519314
    [Abstract] [Full Text] [Related]

  • 20. Adult height in precocious puberty after long-term treatment with deslorelin.
    Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler GB.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.